← Leaderboards
Jinsook Son
Columbia University Health Sciences
$509,375
Attributed
$509,375
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $156.8K · FY2018–25$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$509,375 · 2
By mechanism
K01$461,483 · 1
F32$47,892 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Timothy Cragin Wang$52,188,834
- Domenico Accili$45,709,534
- Anil K Rustgi$51,275,906
- Jianwen Que$22,602,190
- Raul Rabadan$24,791,435
Others in their field
Other Emerging Leaders on “Aldehyde Dehydrogenase 1”
- Angelo D'alessandro · University Of Colorado Denver$5,762,637
- Diana Monsivais · Baylor College Of Medicine$1,966,296
- Satyanarayana Rachagani · University Of Missouri-Columbia$1,860,141
- Mingli Liu · Morehouse School Of Medicine$1,739,500
- Carrie Danielle House · San Diego State University$1,610,593
- Suresh Selvaraj Palaniyandi · Henry Ford Health System$1,517,899
Research focus
Aldehyde Dehydrogenase 1Animal ModelApoptosisBackBeta CellBlood Glucose RegulationB-LymphocytesCell CountCell DedifferentiationCell PhysiologyCellsCell SeparationCessation Of LifeCharacteristicsComplementDb/Db MouseDiabetes MellitusDiabeticDiabetic MouseEndocrineFailureFeedingFunctional DisorderAblation
Grant awards (4)
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of beta cell failure$156,762
K01 · FY2025 · DK · contact PI
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of beta cell failure$151,610
K01 · FY2024 · DK · contact PI
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of beta cell failure$153,111
K01 · FY2023 · DK · contact PI
Analysis of beta cell dedifferentiation using scRNA-seq of human T2D$47,892
F32 · FY2018 · DK · contact PI